Related Experiment Videos
[Laparoscopic sleeve gastrectomy. A bariatric procedure with multiple indications]
Carlos Serra1, Nieves Pérez, Rafael Bou
1Servicio de Cirugía General, Clínica San Jorge y Hospital de Alcoy, Alcoy, Alicante, España.
Cirugia Espanola
|June 7, 2006
Summary
Laparoscopic sleeve gastrectomy (LSG) is effective for superobese and morbidly obese patients with comorbidities. It also serves as a good alternative for lower BMI patients and those needing band conversion.
Area of Science:
- Bariatric surgery
- Minimally invasive procedures
- Gastroenterology
Context:
- Laparoscopic sleeve gastrectomy (LSG) is a restrictive bariatric procedure.
- LSG has diverse applications across various patient profiles.
- The study evaluates LSG outcomes in a cohort of 30 patients.
Purpose:
- To present the clinical experience and outcomes of laparoscopic sleeve gastrectomy (LSG).
- To assess the efficacy of LSG in superobese, morbidly obese with comorbidities, and lower BMI patients.
- To evaluate LSG as a conversion procedure for prior bariatric interventions.
Summary:
- LSG was performed on 30 patients, including those with superobesity, severe comorbidities (e.g., cirrhosis), lower BMI ranges (35-43), and prior band conversion.
- Mortality was 3.2% (1 patient with BMI 74). Excess BMI loss ranged from 13% to 76% depending on patient group and follow-up duration (3-27 months).
- Significant excess weight loss was observed in superobese (63.1%) and cirrhotic patients (76%).
Impact:
- LSG is a suitable primary procedure for patients with BMI > 55 and those with severe comorbidities.
- LSG offers a viable alternative to gastric banding for patients with lower BMI or requiring conversion.
- This experience highlights the versatility and effectiveness of LSG in managing obesity across different patient strata.